Entrada Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TRDA) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -31.61 M-38.51 M-29.49 M-28.31 M-32.2 M -128.51 M Cash from investing activities 53.37 M4.78 M33.8 M49.11 M29.12 M 116.81 M Cash from financing activities 1.4 M350 K337 K8 000192 K 887 K Free cash flow -32.24 M-39.65 M-29.76 M-28.14 M-32 M -129.55 M

뉴스

Entrada Therapeutics Q4 실적 예상치를 넘어, 수익 에상치보다 저조

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)

Entrada reports progress on DMD treatments, shares clinical timeline

TD Cowen, 2026년 바이오 촉매제 10개 이상 주목